Leerink Partnrs Has Negative Estimate for PRVA Q1 Earnings

Privia Health Group, Inc. (NASDAQ:PRVA) – Stock analysts at Leerink Partnrs reduced their Q1 2025 earnings estimates for Privia Health Group in a research report issued on Thursday, February 27th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $0.07 per share for the quarter, down from their prior estimate of $0.08. The consensus estimate for Privia Health Group’s current full-year earnings is $0.14 per share. Leerink Partnrs also issued estimates for Privia Health Group’s Q2 2025 earnings at $0.07 EPS, Q3 2025 earnings at $0.09 EPS, FY2025 earnings at $0.33 EPS, Q1 2026 earnings at $0.10 EPS, Q2 2026 earnings at $0.11 EPS, Q3 2026 earnings at $0.12 EPS, Q4 2026 earnings at $0.13 EPS and FY2027 earnings at $0.61 EPS.

A number of other research firms also recently weighed in on PRVA. JMP Securities reaffirmed a “market outperform” rating and issued a $26.00 price target on shares of Privia Health Group in a research note on Friday, February 14th. Macquarie started coverage on Privia Health Group in a research note on Monday, December 16th. They set an “outperform” rating and a $25.00 price target for the company. Barclays lifted their price target on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a report on Friday, November 8th. Piper Sandler increased their price objective on Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a report on Friday. Finally, Canaccord Genuity Group raised their target price on Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a report on Friday. One analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, Privia Health Group currently has an average rating of “Buy” and a consensus target price of $26.47.

Privia Health Group Stock Down 0.0 %

PRVA stock opened at $24.96 on Monday. The company has a 50 day moving average of $22.50 and a two-hundred day moving average of $20.64. The company has a market cap of $3.00 billion, a price-to-earnings ratio of 249.62, a PEG ratio of 3.47 and a beta of 0.87. Privia Health Group has a 12-month low of $15.92 and a 12-month high of $26.04.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Riverbridge Partners LLC grew its position in Privia Health Group by 19.7% during the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock worth $113,868,000 after buying an additional 958,418 shares in the last quarter. Eventide Asset Management LLC grew its holdings in shares of Privia Health Group by 979.2% during the 3rd quarter. Eventide Asset Management LLC now owns 822,438 shares of the company’s stock worth $14,977,000 after purchasing an additional 746,231 shares in the last quarter. Loomis Sayles & Co. L P increased its position in shares of Privia Health Group by 55.0% during the fourth quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company’s stock valued at $27,727,000 after purchasing an additional 503,002 shares during the period. Durable Capital Partners LP raised its stake in shares of Privia Health Group by 3.4% in the fourth quarter. Durable Capital Partners LP now owns 11,487,843 shares of the company’s stock valued at $224,587,000 after purchasing an additional 378,255 shares in the last quarter. Finally, Icon Wealth Advisors LLC lifted its position in Privia Health Group by 1,910.1% in the third quarter. Icon Wealth Advisors LLC now owns 300,889 shares of the company’s stock worth $5,479,000 after purchasing an additional 285,920 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.